| Biomarker |
Disease / Medical condition |
Imaging Technique |
Investigators |
Comments |
Disease Category |
18 F-fluorodeoxy-glucose |
Pancreatic carcinoma |
PET |
Fischman AJ |
|
Oncology / Neoplasm Gastrointestinal
|
| 99mTc labeled monoclonal antibody |
Colorectal carcinoma |
SPECT |
Fischman AJ |
Phase III clinical trial with HumaSPECT-Tc
|
Oncology / Neoplasm Gastrointestinal |
| Abnormal lymphatic uptake of tracer |
Lymphatic extension of pelvic malignancy (gynecological oncology) |
MRI |
Hahn PF
Harisinghani M
Mueller PR
Saini S
Weissleder R
|
MR Lymphangio-graphy using ultrasmall superpara-magnetic iron oxide |
Oncology / Neoplasm Inflammatory |
| ACCD activation (anterior cingulate cortex division) |
Attention deficit hyperactivity disorder (ADHD) |
fMRI
PET |
Bush G
Fischman A
Rosen B
|
|
Neurological |
| Acinar cell receptor binding |
Pancreatic function |
MRI |
Brady TJ Shen TT Weissleder R |
Secretin monocrystalline iron oxide nanoparticles (MION)
|
Endocrine Metabolic Gastrointestinal |
| Acute bronchial dilatation Wall thickening |
Respiratory syncytial virus |
CT |
McLoud TC
Shepard J
|
|
Infectious disease |
| Altered vascular and tissue permeability |
Asphyxia |
CT |
Gonzalez RG
Grant E
|
|
Neurological |
| Anatomic disruption of arterial wall |
Aortic dissection |
US
CT
MRI
Angiography
|
Gonzalez R
Waltman A
|
|
Cardiology / Vascular |
| Anatomic disruption of arterial wall |
Carotid dissection |
US CT / CTA MRI / MRA Angiography |
Gonzalez R
Waltman A
|
|
Neurological Cardiology / Vascular |
| Anatomic disruption of arterial wall |
Intracranial arterial dissection |
CTA MRA Angiography |
Gonzalez R
Lev MH
Waltman A
|
|
Neurological Cardiology / Vascular |
| Aneurysmal wall thickness |
Inflammatory abdominal aortic aneurysm (IAAA) |
CT |
Brady T
Saini S
Waltman A
|
|
Inflammatory Cardiology / Vascular |
| Angiogenesis |
Breast neoplasm |
US |
O'Neill MJ |
Microbubble contrast agents
|
Oncology / Neoplasm |
| Anterior cingulate size and thickness |
Alzheimer's disease |
MRI |
Hyman B |
Can distinguish normal from mild AD with 93% accuracy
|
Neurological Metabolic |
| Anti-tumor antibody |
Neoplasm / primary and secondary |
Optical |
Ntziachristos V Weissleder R
|
Targeted Fluorochromes |
Oncology / Neoplasm |
| Apoptosis Caspase-1 Caspase-3 |
Neoplasm / primary and secondary |
Optical |
Ntziachristos V Weissleder R
|
Active, stable Fluorochromes |
Oncology / Neoplasm |
| Apoptosis Phosphatidylserine |
Neoplasm / primary and secondary |
Optical |
Ntziachristos V Weissleder R
|
Active, stable Fluorochromes |
Oncology / Neoplasm |
| Apparent diffusion constant (ADC) |
Stroke |
Diffusion weighted imaging fMRI MRI (morphometry) |
Kennedy D
Lo E
Rosen B
|
|
Neurological Cardiology / Vascular |
| Apparent diffusion constant (ADC) |
Neurodegenerative disorders |
fMRI MRI / diffusion weighted imaging |
Jenkins BG
Kennedy D
Rosas HD
Rosen B
|
|
Neurological |
| Arterial calcification |
Atherosclerosis / central |
CT |
Brady T |
|
Cardiology / Vascular Metabolic |
| Arterial calcification |
Arteriosclerosis / peripheral |
CT |
Brady T |
|
Cardiology / Vascular Metabolic |
| Arterial calcification |
Coronary artery disease |
CT |
Brady T |
|
Cardiology / Vascular Metabolic |
| Articular cartilage and subchondral bone thickness |
Cartilage abnormalities |
MRI |
Palmer WE |
MR using fat-suppressed SPGR images
|
Musculoskeletal |
| Articular cartilage thickness |
Arthritis / inflammatory |
Plain radiographs MRI |
Palmer W
Rosenthal DI
|
|
Musculoskeletal Inflammatory |
| Articular cartilage thickness |
Arthritis / rheumatoid |
Plain radiographs MRI |
Palmer W Rosenthal DI
|
|
Musculoskeletal Inflammatory |
| Articular cartilage thickness |
Osteoarthritis |
Plain radiographs MRI |
Palmer W Rosenthal DI
|
|
Musculoskeletal Inflammatory |
| Articular cartilage volume |
Joint injury / hip and knee |
Co-planar MRI |
Palmer WE
Rosenberg AE
Rosenthal DI
|
MR using fat-saturated 3D spoiled gradient-echo images (SPGR)
|
Musculoskeletal |
| Articular labrum fraying |
SLAP lesions of the shoulder |
MR arthrography |
Bencardino JT
Palmer WE
|
|
Musculoskeletal |
| Atherosclerotic plaque temperature |
Vulnerable plaque |
Thermography |
Brady T
Lev M
Waltman A
|
|
Neurological Cardiology/ Vascular Inflammatory |
Basal ganglia / putamen volume
|
Huntington's disease |
MRI |
Harris G |
|
Neurological |
| Bicep anchor avulsion |
SLAP lesions of the shoulder |
MR arthrography |
Bencardino JT
Palmer WE
|
|
Musculoskeletal |
| Biliary ductal dilatation |
Biliary obstruction |
US CT MRI |
Hahn P
Mueller P
|
|
Gastrointestinal |
| Biliary ductal dilatation |
Biliary parasitic disease |
US CT MRI |
Hahn P
Mueller P
O'Neill MJ
|
|
Gastrointestinal Infectious disease |
| Biliary ductal dilatation |
Cholangitis |
MRI |
Prasad S
Sahani D
|
MR cholangio-pancreatography |
Gastrointestinal Infectious disease Inflammatory
|
| Biliary ductal dilatation |
Choledo-cholithiasis |
US CT MRI |
Hahn PF
O'Neill MJ
Mueller P
|
|
Endocrine Inflammatory Gastrointestinal Metabolic
|
| Blood oxygen level depletion |
Neurodegenerative disorders |
fMRI MRI / diffusion weighted imaging |
Jenkins BG
Kennedy D
Rosas HD
Rosen B
|
|
Neurological |
Blood oxygen level depletion (BOLD)
|
Dementia |
fMRI |
Rosen B |
|
Neurological |
| Blood-tumor barrier permeability (BTP) |
Glioma |
MRI fMRI |
Gonzalez RG
Kwong KK
Sorensen AG
Weissleder R
|
|
Neurological Oncology / Neoplasm |
| Body fat composition |
AIDS wasting syndrome |
CT |
Rosenthal DI |
|
Endocrine Metabolic Musculoskeletal Infectious disease Gastrointestinal
|
| Body fat composition |
Obesity |
Quantitative CT MRI US |
Rosenthal DI |
|
Endocrine Metabolic Musculoskeletal Gastrointestinal
|
| Bone fill score and penetration depth |
Bone fracture / healing and distraction osteogenesis wounds |
US |
O'Neill MJ |
Animal study Bone healing assessed by increased fill and decreased penetration depth
|
Musculoskeletal Metabolic |
| Bone mineral density |
Osteopenia |
Plain radiographs Dual energy X-ray absorptiometry (DEXA) CT
|
Rosenthal DI |
Must establish bone strength as well as density |
Endocrine Metabolic Musculoskeletal |
| Bone mineral density |
Osteoporosis |
Plain radiographs Dual energy X-ray absorptiometry (DEXA) CT
|
Rosenthal DI |
Must establish bone strength as well as density |
Endocrine Metabolic Musculoskeletal |
| Bowel wall differentiation |
Crohn's disease |
MR enteroclysis |
Hahn P |
Use of experimental oral contrast Kaolin, locus bean gum, methylcellulose + Barium
|
Gastrointestinal Inflammatory |
| Bowel wall thickening |
Inflammatory bowl disease (IBD)
|
MRI |
Hahn P |
Tissue FISP pulse sequence |
Gastrointestinal Inflammatory |
| Cartilage thickness |
Osteoarthritis |
Intra-articular Optical coherence topography
|
Palmer WE |
|
Musculoskeletal Inflammatory |
| Cathepsin D |
Neoplasm / primary and secondary |
Optical |
Ntziachristos V Weissleder R
|
Active, stable Fluorochromes |
Oncology / Neoplasm |
| Caudate lobe enlargement |
Cirrhosis |
MRI CT |
Hahn PF Sahani D |
Discrimination of alcohol from virus-induced cirrhosis
|
Gastrointestinal Infectious disease Inflammatory |
| Cerebral blood flow |
Alzheimer's disease |
Perfusion weighted imaging / Arterial spin labeling
|
Hoge R |
|
Neurological Metabolic |
| Cerebral blood flow (CBF) |
Alzheimer's disease |
Optical |
Boas D Dunn A |
Combining of multi-wavelength and laser speckle contrast imaging
|
Neurological Metabolic |
| Cerebral blood flow (CBF ) |
Brain function |
MRI fMRI PET |
Belliveau
Kwong K
Rosen BR
|
Response to stimuli |
Neurological Metabolic |
| Cerebral blood flow (CBF) |
Brain development |
Optical Imaging |
Boas D
Dunn A |
Diffuse optical imaging (DOI)
|
Neurological Metabolic |
| Cerebral blood flow (CBF) |
CNS neoplasm / primary and secondary, presence and viability
|
Optical |
Boas D
Dunn A |
Diffuse optical imagine (DOI) |
Neurological Oncology / Neoplasm |
| Cerebral blood flow (CBF) |
Dementia |
MRI / arterial spin labeling
|
Hoge R |
|
Neurological |
| Cerebral blood flow (CBF) |
Epilepsy |
MRI / arterial spin labeling
|
Hoge R
Kwong KK |
|
Neurological |
| Cerebral blood flow (CBF) |
Migraine |
Laser speckle contrast imaging Diffuse optical topography
|
Boas D
Bolay
Dunn A |
|
Neurological |
| Cerebral Blood flow (CBF) |
Stroke |
Optical imaging |
Boas D
Dunn A
Lo E
|
|
Neurological Cardiology / Vascular |
| Cerebral blood flow (CBF) |
Schizophrenia |
PET |
Alpert N
Fischman A
Heckers S
Rauch SL
Schaefer P
|
Regional activation during cognitive paradigms |
Neurological |
| Cerebral blood flow (CBF) |
Parkinson’s disease |
MRI / Arterial spin labeling
|
Hoge R |
|
Neurological |
| Cerebral blood flow (CBF) |
Glioma |
MRI
fMRI |
Gonzalez RG
Sorensen AG
Rosen B
|
|
Neurological Oncology / Neoplasm |
| Cerebral blood flow (CBF) |
Migraine |
Diffusion / perfusion weighted imaging fMRI |
Grant E
Schaefer P
Sorensen AG
Rosen BR
|
|
Neurological |
| Cerebral blood flow (CBF) |
Alzheimer's disease |
SPECT fMRI |
Harris G
Gonzalez RG
Sorensen AG
|
|
Neurological Metabolic |
| Cerebral blood flow (CBF) |
Stroke |
MRI (combined Arterial spin labeling and Dynamic susceptibility contrast) CAPTIVE
|
Harris G
Hoge R
Ostergaard L
Rosen B
Sorensen AG
Wald LL
|
MTT helps to stratify patients in clinical trials MR perfusion territory imaging |
Neurological Cardiology / Vascular |
| Cerebral blood flow (CBF) |
Stroke / ischemic |
CAPTIVE MRI |
Bogdanov A
Jenkins B
Kwong K
Weissleder R
|
|
Neurological Cardiology / Vascular |
| Cerebral blood volume (CBV) |
Brain function / drugs of abuse |
fMRI |
Jenkins B
Kosofsky B
Mandeville JB
Rosen B
|
Response to stimuli |
Neurological Metabolic |
| Cerebral blood volume (CBV) |
Stroke |
MRI (combined Arterial spin labeling and Dynamic susceptibility contrast) CAPTIVE |
Harris G
Hoge R
Ostergaard L
Rosen B
Sorensen AG
Wald LL
|
MTT helps to stratify patients in clinical trials MR perfusion territory imaging |
Neurological Cardiology / Vascular |
| Cerebral blood volume (CBV) |
Glioma |
MRI fMRI |
Gonzalez RG
Sorensen AG
Rosen B
|
|
Neurological Oncology / Neoplasm |
| Cerebral blood volume (CBV) |
Alzheimer's disease |
SPECT fMRI |
Harris G
Gonzalez RG
Sorensen AG
|
|
Neurological Metabolic |
| Cerebral blood volume (CBV) |
Parkinson’s disease |
MRI / Arterial spin labeling |
Hoge R |
|
Neurological |
| Cerebral blood volume (CBV) |
Migraine |
Diffusion / perfusion weighted imaging fMRI |
Grant E
Schaefer P
Sorensen AG
Rosen BR
|
|
Neurological |
| Change in local tissue density or contrast enhancement |
Neoplasm / primary and secondary |
CT MRI |
Palmer WE Rosenthal DI |
Mutlicenter Trail with 367 patients - CT and MRI equally reliable for diagnosis
|
Musculoskeletal Oncology / Neoplasm |
| Chemotactic peptide uptake |
Pancreatitis |
SPECT |
Fischman AJ |
Via 99mTc labeled peptide analog |
Gastrointestinal Inflammatory Metabolic Infectious disease Endocrine
|
| Choline |
CNS AIDS / neuroinflammation neurodegeneration |
MRS |
Gonzalez R
Schaefer P
Schwamm LH
|
|
Neurological |
| Choline |
Hepatic encephalopathy |
MRS |
Grant E
Jenkins BG
Schaefer P
|
|
Neurological |
| Choline |
CNS neoplasm / primary and secondary |
MRS |
Gonzalez R
Husiman TA
Sorensen AG
|
Metabolism, tumor viability and response to therapy |
Neurological Oncology / Neoplasm |
Choline / sodium (NA) ratio Creatine / sodium (NA) ratio
|
Multiple sclerosis |
MRS |
Jenkins B
Gonzalez RG
|
|
Neurological Inflammatory |
| Choline : creatine ratio |
Huntington's disease |
MRS |
Jenkins BG
Rosen B
|
|
Neurological |
| CMRO2 |
Stroke |
fMRI Diffuse optical topography (Near infrared spectroscopy) |
Boas D
Mandeville JB
Strangman G
|
NIRS agrees well with fMRI, useful in longitudinal studies |
Neurological Cardiology / Vascular |
| Comparative brainstem analysis |
Multiple sclerosis |
MRI |
Jenkins B
Rosen BR
Stufflebeam SM
|
|
Neurological Inflammatory |
| Contrast enhanced tissue characterization |
Pancreatic mass |
MRI cholangio -pancreatography |
Prasad S
Sahani D
Saini S
|
|
Oncology / Neoplasm Gastrointestinal |
| Cortical thickness |
Schizophrenia |
MRI (morphometry) |
Fischl B
Harris G
Kennedy D
Kuperberg G
|
|
Neurological |
| Cortical activation during provoked conditions |
Obsessive compulsive disorder |
fMRI PET SPECT |
Fischman A
Rauch SL
Rosen BR
|
|
Neurological |
Cortical activation during sensorimotor tasks
|
Stroke / recovery |
fMRI |
Schaechter J Rosen BR |
|
Neurological Cardiology / Vascular |
| Cortical activity |
Pain |
fMRI PET SPECT MEG |
Fischman A
Halgren E
Rosen B
Sorensen AG
Stuffelbeam SM
|
|
Neurological Musculoskeletal |
| Cortical dysplasia |
Epilepsy |
MRI / MEG fMRI |
Dale A
Grant E
Mandeville J
Rosen B
Stufflebeam SM
Wald LL
|
|
Neurological |
| Cortical spreading depression (CSD) |
Migraine |
Blood oxygen level dependent (BOLD) fMRI |
Hadjikhani N
Rosen BR
Sorensen AG
|
Signal changes measured during visual aura |
Neurological |
| Cortical surface disruption |
Bone fracture |
Plain radiographs |
Palmer W Rosenthal DI
|
|
Musculoskeletal |
| Cortical thickness |
Huntington's disease |
fMRI MRI morphometry |
Dale A
Fischl B
Harris G
Kennedy D
Rosas D
|
|
Neurological |
| Cortical thickness |
Multiple sclerosis |
fMRI
MRI
morphometry
|
Fischl B
Kuperberg G
|
|
Neurological Inflammatory |
| Cortical thickness |
Obsessive compulsive disorder
|
MRI (morphometry) |
Kennedy D |
|
Neurological |
| Cortical thickness and asymmetry |
Attention deficit hyperactivity disorder (ADHD)
|
MRI (morphometry) |
Kennedy D |
|
Neurological |
| Cortical thickness, volume and location |
Brain development / -anencephaly -microcephaly -holoprosencephaly
|
MRI morphometry fMRI |
Caviness VS
Dale A
Fischl B
Kennedy D
|
|
Neurological |
| Cyst composition / tissue characterization |
Intra-abdominal abscess |
US CT MRI |
Mueller P |
|
Gastrointestinal Genitourinary Infectious disease
|
| Cyst composition / tissue characterization |
Arthritis / septic |
PET |
Palmer W Rosenthal DI |
|
Infectious disease Musculoskeletal Inflammatory
|
| Cyst composition / tissue characterization |
Fibrocystic change |
US
CT
MRI
|
Kopans DB |
|
Oncology / Neoplasm |
| Cyst composition / tissue characterization |
Ganglion cyst |
US
CT
MRI
|
Rosenthal DI |
|
Musculoskeletal Inflammatory |
| Cyst composition / tissue characterization |
Renal neoplasm / primary and secondary |
US
CT
MRI
|
Mueller PR |
|
Oncology / Neoplasm Genitourinary |
| Cyst composition / tissue characterization |
Synovial cell sarcoma |
US
CT
MRI
|
Rosenthal DI |
|
Oncology / Neoplasm Musculoskeletal |
| Cyst composition / tissue characterization Soft tissue inflammation |
Simple renal cysts |
US
CT
MRI
|
Mueller PR |
|
Oncology / Neoplasm Genitourinary |
| Cystic architecture / tissue characterization |
Synovial cyst |
US
CT
MRI
|
Palmer W Rosenthal DI |
|
Musculoskeletal |
| Cystic nodal metastases |
Thyroid carcinoma |
US |
Hahn PF
Harisinghani M
Mueller PR
O'Neill MJ
|
|
Oncology / Neoplasm Endocrine |
| Decreased N-acetylaspartate (NAA) |
Multiple sclerosis |
MRS |
Jenkins B Gonzalez RG
|
|
Neurological Inflammatory |
| Decreased regional blood flow |
Renal disease |
PET |
Alpert NM Fischman AJ
|
|
Metabolic Endocrine |
| Degree of circumferential vessel involvement |
Pancreatic adrenal carcinoma |
Multidetector CT angiography (MDCT) / CTA |
Boland GW
Mueller PR
Saini S
|
|
Oncology / Neoplasm Gastrointestinal |
Diffuse cerebral edema with thalamic +/- cerebellar hypo-attenuation
|
Cerebral malaria |
CT |
Gonzalez RG |
|
Neurological Infectious disease |
| Diffuse cerebral edema with thalamic +/- cerebellar hypo-attenuation |
Infectious disease / cerebral malaria |
CT |
Gonzalez RG |
|
Neurological Infectious disease |
| Directed molecular probes |
HIV |
MRI
PET
Optical
|
Weissleder R
|
|
Infectious disease |
| Directed molecular probes |
Huntington's disease |
MRI
PET
Optical
|
Fischman A Weissleder R |
|
Neurological |
| Directed molecular probes |
Neoplasm / primary and secondary |
MRI
PET
Optical
|
Fischman AJ Hunter GJ Weissleder R |
|
Oncology / Neoplasm |
| Directed molecular probes |
Parkinson’s disease |
PET
Optical
|
Weissleder R |
|
Neurological |
| Directed molecular probes |
Alzheimer's disease |
PET SPECT Optical |
Fischman A Weissleder R |
Animal modeling Optical with exogenous contrast agents
|
Neurological Metabolic |
| Directed molecular probes for beta cell mass |
Diabetes |
MRI |
Moore A
Bogdanov AJ
Weissleder R
|
|
Metabolic Endocrine |
Distribution and leakage of intra-articular administered contrast media
|
Rotator cuff injury |
MR arthrography |
Palmer WE |
Distinguishes full from partial thickness tears |
Musculoskeletal |
Dopa decarboxylase activity
|
Dyskinesia (PNKD) |
PET |
Fischman A |
|
Neurological Musculoskeletal |
| Dopamine binding potential |
Parkinson’s disease |
SPECT (using I-123 altropane) |
Fischman A
Halpern E
Sahani D
|
|
Neurological |
| Dopamine transporter (DAT) density |
Parkinson’s disease |
SPECT (using I-123 altropane) |
Fischman A
Halpern E
Sahani D
|
|
Neurological |
| Dopamine transporter density |
Attention deficit hyperactivity disorder (ADHD)
|
SPECT |
Fischman A Rauch SL |
|
Neurological |
| Dopaminergic neurotransmitter activity |
Parkinson’s disease |
fMRI PET |
Fishman A
Livni E
Rosen B
|
Pet using 11C-CRT |
Neurological |
| Ductal dilatation |
Cholangitis |
MRI |
Prasad S Sahani D |
MR cholangio- pancreatography |
Gastrointestinal Infectious disease Inflammatory
|
| Ductal irregularity or obstruction |
Pancreatitis |
MRI |
Prasad S Sahani D Saini S |
Visualized by MR cholanio-pancreatography (MRCP)
|
Gastrointestinal Inflammatory Metabolic Infectious disease Endocrine |
| Early diffusion changes |
Asphyxia |
Diffusion weighted imaging |
Grant E
Schaefer P
Sorensen AG
|
|
Neurological |
Edema / change in signal intensity and apparent diffusion constant
|
Trauma |
MRI Diffusion weighted imaging |
Palmer W Rosenthal DI |
|
Musculoskeletal Inflammatory |
| Embolism volume |
Pulmonary embolism |
MRI |
Weissleder R |
Via monocrystalline iron oxide nanoparticles (MION)
|
Cardiology / Vascular |
| Entorhinal cortex |
Alzheimer's disease |
MRI |
Hyman B |
Can distinguish normal from mild AD with 93% accuracy
|
Neurological Metabolic |
| Enzymatic activity |
Neoplasm / primary and secondary
|
Optical |
Weissleder R |
Rodent model |
Oncology / Neoplasm |
| Fibrillations |
Osteoarthritis |
Intra-articular Optical coherence topography
|
Palmer WE |
|
Musculoskeletal Inflammatory |
| Fibrosis |
Osteoarthritis |
Intra-articular Optical coherence topography
|
Palmer WE |
|
Musculoskeletal Inflammatory |
| Fibrous cap thickness |
Vulnerable plaque |
Optical coherence topography |
Weissleder R |
|
Neurological Cardiology / Vascular Inflammatory
|
| Flow heterogeneity (FH) |
Stroke |
MRI (combined Arterial spin labeling and Dynamic susceptibility contrast) CAPTIVE
|
Harris G
Hoge R
Ostergaard L
Rosen B
Sorensen AG
Wald LL
|
MTT helps to stratify patients in clinical trials MR perfusion territory imaging |
Neurological Cardiology / Vascular |
| Fluorescent proteins / exogenous |
Neoplasm / primary and secondary |
Macroscopic fluorescence reflective imagine (FRI) Fluorescence molecular tomography (FMT)
|
Ntziachristos V Weissleder R |
Green fluorescence proteins (GFPs) Ds Red Hc Red |
Oncology / Neoplasm |
| Focal atrophy |
Brain injury / toxicity and trauma |
MRI |
Caviness VS
Kennedy D
|
|
Neurological |
| Focal brain uptake |
CNS AIDS / fungal and opportunistic infections
|
PET SPECT |
Fischman A |
|
Neurological |
| Folate receptor |
Neoplasm / primary and secondary |
Optical |
Ntziachristos V Weissleder R
|
Targeted Fluorochromes |
Oncology / Neoplasm |
| Frontal language area |
Autism |
MRI |
Caviness VS
Harris G
Kennedy D
|
Reversal of morphometric asymmetry in frontal language area
|
Neurological |
| Frontal language area |
Autism |
fMRI |
Harris G |
Abnormal fMRI activation of frontal language areas during semantic language tasks
|
Neurological |
| Gallbladder wall thickening |
Cholecystitis |
US
CT
MRI |
Hahn P
Mueller P
O'Neill MJ |
|
Endocrine Inflammatory Infectious disease Gastrointestinal
|
| Gallstones |
Cholelithiasis |
US
CT
MRI |
Hahn P
Mueller P
O'Neill MJ |
|
Endocrine Inflammatory Gastrointestinal Metabolic
|
| Gallstones |
Cholecystitis |
US
CT
MRI |
Hahn P
Mueller P
O'Neill MJ |
|
Endocrine Inflammatory Infectious disease Gastrointestinal
|
| Glucose |
Hepatic encephalopathy |
MRS |
Grant E
Jenkins BG
Schaefer P
|
|
Neurological |
| Glucose metabolism |
Breast neoplasm |
PET |
Alpert NM
Choi NC
Fischman AJ
|
|
Oncology / Neoplasm |
| Glucose metabolism |
Head and neck neoplasm / primary and secondary |
PET |
Alpert N
Choi N
Fischman A
|
Non-specific marker with wide variety of applications |
Neurological Oncology / Neoplasm |
| Glucose metabolism |
Hepatic neoplasm / primary and secondary |
PET |
Fischman AJ |
Non-specific marker with wide variety of applications
|
Oncology / Neoplasm Gastrointestinal |
| Glucose metabolism |
Lung neoplasm / non small cell carcinoma |
PET |
Choi NC
Fischman AJ
Weissleder R |
Pilot trial in NSCLC showed good inverse correlation between MR post radiation and outcomes
|
Oncology / Neoplasm |
| Glucose metabolism |
Osseous neoplasm / primary and secondary
|
PET |
Fischman AJ |
|
Oncology / Neoplasm Musculoskeletal |
| Glucose metabolism |
Ovarian neoplasm / presence and viability |
PET |
Fischman AJ |
Non-specific marker with wide variety of applications
|
Oncology / Neoplasm Genitourinary |
| Glucose metabolism |
Pulmonary neoplasm / presence and viability |
PET |
Fischman AJ |
Non-specific marker with wide variety of applications
|
Oncology / Neoplasm |
| Glucose metabolism |
Renal neoplasm / primary and secondary |
PET |
Fischman AJ |
|
Oncology / Neoplasm Genitourinary
|
| Glucose metabolism |
Soft tissue neoplasm / primary and secondary |
PET |
Fischman AJ |
Non-specific marker with wide variety of applications
|
Oncology / Neoplasm Musculoskeletal |
| Glucose metabolism |
CNS neoplasm / primary and secondary, presence and viability |
PET |
Alpert N
|
